期刊
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fcimb.2022.962782
关键词
intestinal microbiota; metabolites; intestinal ischemia reperfusion; intestinal dysbiosis; biomarkers
资金
- Shiyan Taihe Hospital Scientific Research Supporting Fund [2019SCI013]
Intestinal ischemia/reperfusion (II/R) is a common acute and critical condition with a lack of effective prevention and treatment measures. The gut microbiota has been found to play a pivotal role in II/R, and maintaining the homeostasis of the gut microbiota and its metabolites may be a potential strategy for treatment. This review highlights the importance of the crosstalk between the gastrointestinal ecosystem and II/R, and discusses the potential applications of microbial-based therapies in II/R.
Intestinal ischemia/reperfusion (II/R) is a common acute and critical condition in clinical practice with a high mortality rate. However, there is still a lack of effective prevention and treatment measures for II/R injury. The role of the gut microbiota in II/R has attracted widespread attention. Recent evidence has demonstrated that the gut microbiota plays a pivotal role in the occurrence, development, and prognosis of II/R. Therefore, maintaining the homeostasis of gut microbiota and its metabolites may be a potential strategy for the treatment of II/R. This review focuses on the importance of crosstalk between the gastrointestinal ecosystem and II/R to highlight II/R-induced gut microbiota signatures and potential applications of microbial-based therapies in II/R. This will also provide potentially effective biomarkers for the prediction, diagnosis and treatment of II/R.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据